Bengaluru, June 22, 2017: Worldwide, cancer is on the way to equaling cardiac disease as the biggest killer. In India, it is now the second biggest killer, after heart disease and stroke, up from seventh position in 2000, reports the World Health Organization (WHO).
Innovative diagnostic facilities in cancer treatment are opening a whole new world for possible early diagnosis and cures. The first treatment for a rare form of skin cancer – Syringocystadeno carcinoma paplliferum, diagnosed and treated by Dr.Anthony Pais at Cytecare cancer hospital, Bengaluru, is one such case where the right diagnosis was the game-changer in the treatment of the disease, which was discussed at a press briefing on 22nd June at Taj Vivanta.
Addressing the press, Dr Anthony Pais, a renowned breast cancer surgeon as well as Co-founder and Clinical Director, Cytecare said, “There are two types of skin cancer – melanoma and non-melanoma. Across the globe, if you take the percentage of skin cancer cases, most of them are non-melanoma. Among all the non-melanoma skin cancers, 75% of them are basal cell cancers, 20% of them are squamous cell cancers and about 2% of them being adnexal skin tumours. Most of these adnexal tumours are benign. The rarity of this adnexal skin cancer, involving the breast is the rarest of cancers. In this case, the problem started with a wart and with a birth mark close by, which is technically called a nevus. This grew over a period of time, involving the breast. Most often it is benign but there is 10% chance of being malignant.”
Reflecting upon the diagnosis, he said, “It is very difficult to know about the disease or diagnose it at an early stage. So, there is no precaution and it can’t be prevented. Moreover, it is not genetic. Excessive exposure to sunlight can be one of the reasons and so our farmers are at greater risk. One might diagnose this case to be that of a breast cancer and a wrong diagnosis means unnecessary chemotherapy. The treatment is for the skin cancer arising on the breast, infiltrating into it. So, proper surgery and radiotherapy is the answer.
Even mammography is of no help, as it can detect only breast cancer and not a type of skin cancer on the breast. So, self-examination of the breast, including the skin, is the only precaution one can take.”
Speaking at the briefing, Suresh Ramu, Co-Founder and CEO, Cytecare said, "'Fighting cancer the right way' is our philosophy and this case helps us to demonstrate our principle, loud and clear. We practice approaches that help us to diagnose and treat cancer with utmost accuracy and precision"
Talking about her joy on being on the path to recovery, Amina expressing her gratitude, in view of the meticulous care received at Cytecare, Mrs Amina, The patient from Nigeria says, “I suddenly found a lump on the left breast in November 2014 was then diagnosed as chronic mastitis in local hospital in Nigeria. I put on a lot of antibiotics and then underwent surgery, wherein, the biopsy report suggested papillary carcinoma. With no proper treatment plan and lack of direction, I felt horrible. In the last three years, in the absence of right diagnosis, lack of treatment and no one to approach, I had kind of lost hope.”
She adds, “My family and I got very anxious about this situation and on the recommendation of a local doctor decided to visit Dr. Anthony Pais at Cytecare for treatment. It has been a miraculous experience since the time I have been here. I have got the best doctor and the best treatment, my pathogenic condition is under good control and my physical condition has improved, through series of treatments. Cancer changes your life, Sometimes for the better.”
The word ‘cyte’ is derived from the Greek word, ‘kytos’, which means cell. We represent care at a cellular level.
Our principle is, Fighting Cancer the Right Way. Cytecare provides highly specialized, modern diagnostic services, treatment and care for Cancer. We believe and understand that every cancer is different and hence, specialized treatment is necessary to be provided for each. We are practitioners of researched cancer care methodologies, owing to which, our multi-disciplinary team of clinicians is strongly guided by national as well as global protocols such as the National Comprehensive Cancer Network (NCCN), European Society for Medical Oncology (ESMO), National Health Service (NHS), Indian Council of Medical Research (ICMR) and Tata Memorial Hospital. Cytecare promotes deeper understanding of individuals and their treatments.
Online Coverage Links:
Standing out in the cancer
India needs to develop consensus
The investment will be used
Have the core characteristics, expectations
CANCON-2018 saw deliberations on establishing